TeraImmune LLC is a pre-clinical stage startup company developing immune cell therapeutics using human regulatory T cells.

 

We use regulatory T (Treg) cells from a donor (=recipient, aka., autologous cell therapy) and make Treg cells as a therapeutic against autoimmune diseases and immune-related disorders.

 

The process is as following:
1. Isolation of Treg cells from the donor’s whole blood 
2. Modification of Treg cells with a receptor to specifically recognize target cell (T cell, B cell or Antigen Presenting Cell)
3. Expansion of modified Treg cells

gallery/picture1